vs
AMICUS THERAPEUTICS, INC.（FOLD）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是AMICUS THERAPEUTICS, INC.的1.1倍（$207.8M vs $185.2M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 0.9%，领先56.5%），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $16.0M）
Amicus Therapeutics是总部位于美国宾夕法尼亚州费城的生物制药上市企业，2007年在纳斯达克挂牌上市，股票代码为FOLD。上市前，公司曾获得Radius Ventures、迦南合伙人、恩颐投资等多家风险投资机构的资金支持，专注于生物医药领域的研发与商业化布局。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
FOLD vs IDYA — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$185.2M
净利率更高
IDYA
高出56.5%
0.9%
自由现金流更多
IDYA
多$126.2M
$16.0M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.2M | $207.8M |
| 净利润 | $1.7M | $119.2M |
| 毛利率 | 85.7% | — |
| 营业利润率 | 8.6% | 52.2% |
| 净利率 | 0.9% | 57.4% |
| 营收同比 | 23.7% | — |
| 净利润同比 | -88.5% | 330.1% |
| 每股收益（稀释后） | $0.00 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FOLDIDYA
| Q4 25 | $185.2M | — | ||
| Q3 25 | $169.1M | $207.8M | ||
| Q2 25 | $154.7M | — | ||
| Q1 25 | $125.2M | — | ||
| Q4 24 | $149.7M | — | ||
| Q3 24 | $141.5M | $0 | ||
| Q2 24 | $126.7M | $0 | ||
| Q1 24 | $110.4M | $0 |
净利润FOLDIDYA
| Q4 25 | $1.7M | — | ||
| Q3 25 | $17.3M | $119.2M | ||
| Q2 25 | $-24.4M | — | ||
| Q1 25 | $-21.7M | — | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $-6.7M | $-51.8M | ||
| Q2 24 | $-15.7M | $-52.8M | ||
| Q1 24 | $-48.4M | $-39.6M |
毛利率FOLDIDYA
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
营业利润率FOLDIDYA
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.3% | 52.2% | ||
| Q2 25 | -6.1% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | -25.1% | — |
净利率FOLDIDYA
| Q4 25 | 0.9% | — | ||
| Q3 25 | 10.2% | 57.4% | ||
| Q2 25 | -15.8% | — | ||
| Q1 25 | -17.3% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | -4.8% | — | ||
| Q2 24 | -12.4% | — | ||
| Q1 24 | -43.9% | — |
每股收益（稀释后）FOLDIDYA
| Q4 25 | $0.00 | — | ||
| Q3 25 | $0.06 | $1.33 | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $-0.02 | $-0.60 | ||
| Q2 24 | $-0.05 | $-0.68 | ||
| Q1 24 | $-0.16 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $293.5M | $786.9M |
| 总债务越低越好 | $392.7M | — |
| 股东权益账面价值 | $274.2M | $1.1B |
| 总资产 | $949.9M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.43× | — |
8季度趋势，按日历期对齐
现金及短期投资FOLDIDYA
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | $786.9M | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | $920.0M | ||
| Q2 24 | $260.1M | $701.7M | ||
| Q1 24 | $239.6M | $698.8M |
总债务FOLDIDYA
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
股东权益FOLDIDYA
| Q4 25 | $274.2M | — | ||
| Q3 25 | $230.4M | $1.1B | ||
| Q2 25 | $204.3M | — | ||
| Q1 25 | $193.6M | — | ||
| Q4 24 | $194.0M | — | ||
| Q3 24 | $178.8M | $1.2B | ||
| Q2 24 | $132.5M | $931.7M | ||
| Q1 24 | $130.7M | $935.3M |
总资产FOLDIDYA
| Q4 25 | $949.9M | — | ||
| Q3 25 | $868.8M | $1.2B | ||
| Q2 25 | $815.3M | — | ||
| Q1 25 | $789.8M | — | ||
| Q4 24 | $785.0M | — | ||
| Q3 24 | $786.6M | $1.2B | ||
| Q2 24 | $749.5M | $973.7M | ||
| Q1 24 | $721.8M | $961.5M |
负债/权益比FOLDIDYA
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.3M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $142.2M |
| 自由现金流率自由现金流/营收 | 8.6% | 68.4% |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 9.62× | 1.19× |
| 过去12个月自由现金流最近4个季度 | $29.8M | $13.5M |
8季度趋势，按日历期对齐
经营现金流FOLDIDYA
| Q4 25 | $16.3M | — | ||
| Q3 25 | $35.7M | $142.2M | ||
| Q2 25 | $-26.5M | — | ||
| Q1 25 | $7.8M | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $-23.0M | $-49.2M | ||
| Q2 24 | $22.7M | $-32.9M | ||
| Q1 24 | $-29.7M | $-43.8M |
自由现金流FOLDIDYA
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | $142.2M | ||
| Q2 25 | $-28.9M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | $-49.7M | ||
| Q2 24 | $21.6M | $-33.9M | ||
| Q1 24 | $-31.5M | $-45.1M |
自由现金流率FOLDIDYA
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.9% | 68.4% | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | -28.5% | — |
资本支出强度FOLDIDYA
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.6% | — |
现金转化率FOLDIDYA
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
IDYA
暂无分部数据
